EUVIMEDEUVIMED entdecken
Crossref

Xanthohumol ameliorates drug-induced hepatic ferroptosis via activating Nrf2/xCT/GPX4 signaling pathway

Yanyan Deng, Xiayan Chu, Qian Li, Guanghao Zhu, Jing Hu, Jianming Sun, Hairong Zeng, Jian Huang, Guangbo Ge

Phytomedicine · 2024-04 · 126 · 155458

DOI: 10.1016/j.phymed.2024.155458 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2024-04. Verfasst von Yanyan Deng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Tradi…. Hauptthemen laut MEDLINE: Ferroptosis, Flavonoids, Propiophenones. Die Arbeit wurde bisher 76-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Ministry of Science and Technology of the People's Republic of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: As a canonical iron-dependent form of regulated cell death (RCD), ferroptosis plays a crucial role in chemical-induced liver injuries. Previous studies have demonstrated that xanthohumol (Xh), a natural prenylflavonoid isolated from hops, exhibits anti-inflammatory, anti-antioxidative and hepatoprotective properties. However, the regulatory effects of Xh on hepatic ferroptosis and the underlying mechanism have not yet been fully elucidated. PURPOSE: To investigate the hepatoprotective effects of Xh against drug-induced liver injury (DILI) and the regulatory effects of Xh on hepatic ferroptosis, as well as to reveal the underlying molecular mechanisms. METHODS/STUDY DESIGN: The hepatoprotective benefits of Xh were investigated in APAP-induced liver injury (AILI) mice and HepaRG cells. Xh was administered intraperitoneally to assess its in vivo effects. Histological and biochemical studies were carried out to evaluate liver damage. A series of ferroptosis-related markers, including intracellular Fe2+ levels, ROS and GSH levels, the levels of MDA, LPO and 4-HNE, as well as the expression levels of ferroptosis-related proteins and modulators were quantified both in vivo and in vitro. The modified peptides of Keap1 by Xh were characterized utilizing nano LC-MS/MS. RESULTS: Xh remarkably suppresses hepatic ferroptosis and ameliorates AILI both in vitro and in vivo, via suppressing Fe2+ accumulation, ROS formation, MDA generation and GSH depletion, these observations could be considerably mitigated by the ferroptosis inhibitor ferrostatin-1 (Fer-1). Mechanistically, Xh could significantly activate the Nrf2/xCT/GPX4 signaling pathway to counteract AILI-induced hepatocyte ferroptosis. Further investigations showed that Xh could covalently modify three functional cysteine residues (cys151, 273, 288) of Keap1, which in turn, reduced the ubiquitination rates of Nrf2 and prolonged its degradation half-life. CONCLUSIONS: Xh evidently suppresses hepatic ferroptosis and ameliorates AILI via covalent modifying three key cysteines of Keap1 and activating Nrf2/xCT/GPX4 signaling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisFlavonoidsPropiophenonesAnimalsMiceKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2Reactive Oxygen SpeciesTandem Mass SpectrometryLiverSignal TransductionCysteine

Stichwörter der Autor:innen

Drug-induced liver injuryFerroptosisGPX4Nrf2/Keap1XanthohumolxCT

Substanzen

xanthohumolKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2Reactive Oxygen SpeciesCysteineFlavonoidsPropiophenones

Autor:innen und Institutionen

  • Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine. Shanghai 201203, China.
  • Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, 200120, China.
  • Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine. Shanghai 201203, China. Electronic address: h…
  • Pharmacology and Toxicology Division, Shanghai Institute of Food and Drug Control, Shanghai 201203, China.
  • Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine. Shanghai 201203, China. Electronic address: g…

Förderung

  • National Natural Science Foundation of China
  • Ministry of Science and Technology of the People's Republic of China

Zitieren

APA

Deng, Y., Chu, X., Li, Q., Zhu, G., Hu, J., Sun, J., Zeng, H., Huang, J., & Ge, G. (2024). Xanthohumol ameliorates drug-induced hepatic ferroptosis via activating Nrf2/xCT/GPX4 signaling pathway. Phytomedicine, 126, 155458. https://doi.org/10.1016/j.phymed.2024.155458

Vancouver

Deng Y, Chu X, Li Q, Zhu G, Hu J, Sun J, et al. Xanthohumol ameliorates drug-induced hepatic ferroptosis via activating Nrf2/xCT/GPX4 signaling pathway. Phytomedicine. 2024;126:155458. doi:10.1016/j.phymed.2024.155458

BibTeX
@article{Deng2024,
  author = {Deng, Yanyan and Chu, Xiayan and Li, Qian and Zhu, Guanghao and Hu, Jing and Sun, Jianming and Zeng, Hairong and Huang, Jian and Ge, Guangbo},
  title = {Xanthohumol ameliorates drug-induced hepatic ferroptosis via activating Nrf2/xCT/GPX4 signaling pathway},
  journal = {Phytomedicine},
  year = {2024},
  volume = {126},
  pages = {155458},
  doi = {10.1016/j.phymed.2024.155458}
}
Kostenlos starten →